The oral NK1 antagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting: a multinational, randomized, double-blind, placebo controlled trial in patients receiving high-dose cisplatin

PJ Hesketh, SM Grundberg, RJ Gralla, DG Warr, F Roila, Ronald de Wit, SP Chawla, AD Carides, J Ianus, ME Elmer, JK Evans, K Beck, S Reines, KJ Horgan

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)4112-4119
Number of pages8
JournalJournal of Clinical Oncology
Publication statusPublished - 2003

Research programs

  • EMC MM-03-86-08
  • EMC OR-01-86-13

Cite this